Goldman Sachs Group Inc Talaris Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 14, 2024	BUY	$2.68 - $3.22 $23,436 - $28,158	8,745 New	8,745 $24,000
Q3 2023 Nov 14, 2023	SELL	$2.68 - $3.22 $28,016 - $33,661	-10,454 Reduced 54.45%	8,745 $24,000
Q2 2023 May 14, 2024	SELL	$1.78 - $3.2 $3,125 - $5,619	-1,756 Reduced 8.38%	19,199 $58,000
Q2 2023 Aug 14, 2023	SELL	$1.78 - $3.2 $3,125 - $5,619	-1,756 Reduced 8.38%	19,199 $58,000
Q1 2023 May 14, 2024	SELL	$1.09 - $2.09 $20,632 - $39,561	-18,929 Reduced 47.46%	20,955 $39,000
Q1 2023 May 11, 2023	SELL	$1.09 - $2.09 $20,632 - $39,561	-18,929 Reduced 47.46%	20,955 $39,000
Q4 2022 May 14, 2024	BUY	$0.94 - $1.64 $7,115 - $12,414	7,570 Added 23.43%	39,884 $40,000
Q4 2022 Feb 13, 2023	BUY	$0.94 - $1.64 $7,115 - $12,414	7,570 Added 23.43%	39,884 $40,000
Q3 2022 May 14, 2024	BUY	$2.3 - $5.03 $18,144 - $39,681	7,889 Added 32.3%	32,314 $85,000
Q3 2022 Nov 10, 2022	BUY	$2.3 - $5.03 $18,144 - $39,681	7,889 Added 32.3%	32,314 $0
Q2 2022 May 14, 2024	BUY	$4.51 - $9.85 $110,156 - $240,586	24,425 New	24,425 $110,000
Q2 2022 Aug 15, 2022	SELL	$4.51 - $9.85 $1,785 - $3,900	-396 Reduced 1.6%	24,425 $110,000
Q1 2022 May 16, 2022	BUY	$6.89 - $16.56 $11,940 - $28,698	1,733 Added 7.51%	24,821 $244,000
Q4 2021 Feb 14, 2022	BUY	$12.18 - $17.0 $281,211 - $392,496	23,088 New	23,088 $353,000

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.